Die Onkologie pp 259-280 | Cite as

Krebserkrankungen als Folge ionisierender Strahlung

  • W. Gassmann
  • H. P. Rodemann
Chapter

Zusammenfassung

Obwohl schon seit langem bekannt ist, dass ionisierende Strahlung Leukämien und andere Krebserkrankungen auslösen kann (Andrieu et al.1990; Baccarani et al.1980; Bartolucci et al.1983; Boice et al.1996; Gassmann u. Slanina 1993; Glicksman et al. 1982; Sabatier et al. 1995; Valagussa et al.1986,1987), wurde diese Gefahr lange Zeit aus dem Bewusstsein verdrängt und es erfolgte ein relativ sorgloser Umgang mit potentiellen Expositionen. So waren beispielsweise in den 50er-Jahren besonders fortschrittliche Schuhgeschäfte mit Röntgengeräten ausgestattet, in denen insbesondere für Kinder der Sitz der neuen Schuhe überprüft werden konnte. Im Rahmen militärischer Übungen wurden US-Soldaten bewusst der radioaktiven Strahlung von Atombomben ausgesetzt.

This is a preview of subscription content, log in to check access.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. Abrahamsen JF, Andersen A, Hannisdal E, Nome O, Abrahamsen AF, Kvaloy S, Host H (1993) Second malignancies after treatment of Hodgkin’s disease.The influence of treatment,follow-up time, and age.J Clin Oncol 11: 255–261Google Scholar
  2. Aisenberg AC, Finkelstein DM, Doppke KP, Koemer FC, Boivin JF,Willett CG (1997) High risk of breast carcinoma after irradiation of young women with Hodgkin’s disease.Cancer 79: 1203–1210Google Scholar
  3. Ajiki W, Hanai A,Tsukuma H, Hiyama T, Fujimoto I (1994) Incidence of childhood cancer in Osaka, Japan, 1971–1988. Reclassification of registered Gases by Birch’s scheme using information an clinical diagnosis, histology and primary site.Jpn J Cancer Research 85: 139–146Google Scholar
  4. Alexander FE, McKinney PA, Ricketts TJ, Cartwright RA (1993) Community lifestyle characteristics and risk of acute lymphoblastic leukaemia in children. Lancet 336: 1461–1465Google Scholar
  5. Andersson M, Carstensen B, Visfeldt J (1993) Leukemia and other related hematological disorders among Danish patients exposed to Thorotrast. Rad Research 134: 224–233Google Scholar
  6. Andersson M,Juel K, Ishikawa Y, Storm HH (1994) Effects of preconception-al irradiation on mortality and cancer incidence in the offspring of patients given injections of thorotrast.J Nat Cancer Inst 86: 1866–1870Google Scholar
  7. Andersson M, Storm HH (1992) Cancer incidence among Danish thorotrast-exposed patients. J Nat Cancer Inst 84: 1318–1325PubMedGoogle Scholar
  8. Andersson M,Vyberg M,Visfeldt J, Carstensen B, Storm HH (1994) Primary liver tumors among Danish patients exposes to thorotrast. Rad Research 137: 262–273Google Scholar
  9. Andersson M (1997) Long-term effects of internally deposited alpha-particle emitting radionuclides. Epidemiological,pathological and molecular-biological studies of Danish Thorotrast-administered patients and their offspring. Dan Med Bull 44, 169–90, 1997PubMedGoogle Scholar
  10. Andrieu J-M, Ifrah N, Payen C, Fermanian J, Coscas Y, Flandrin G (1990) Increased risk of secondary acute nonlymphocytic leukemia after extended-field radiation therapy combined with MOPP chemotherapy for Hodgkin’s disease.J Clin Onco18: 1148–1154Google Scholar
  11. Arai T, NakanoT,Fukuhisa Ket al. (1991) Second cancer after radiation therapy for cancer of the uterine cervix. Cancer 67: 398–405Google Scholar
  12. Armitage JO, Dick FR, Goeken A, Foucar K, Gingrich RD (1983) Second lymphoid malignant neoplasms occuring in patients treated for Hodgkin’s disease. Arch Int Med 143: 445–450Google Scholar
  13. Auvinen A, Hakama M, Arvela H et al. (1994) Fall-out from Chernobyl and incidence of childhood leukaemia in Finland, 1976–92. Brit Med J 309: 151–154PubMedGoogle Scholar
  14. Baccarani M, Bosi A, Papa G (1980) Writing Committee for The Gigi GhirottiTask Force for Malignant Lymphoma.Second Malignancy in patients treated for Hodgkin’s disease. Cancer 46: 1735–1740PubMedGoogle Scholar
  15. Bau N, Kai M, Kusama T (1997) Chromosome aberrations in bone marrow cells of C3H/He mice at an early stage after whole-body irradiation.J Rad Research 38: 219–231Google Scholar
  16. Barrie RC, Walsh WP, Lusk EJ (1988) Psychosocial correlates of cancer survival.A subsequent report 3 to 8years after cancer diagnosis.J Clin On-col 6: 1753–1759Google Scholar
  17. Bartolucci AA, Liu C, Durant JR, Gams RA (1983) Acute myelogenous leukemia as a second malignant neoplasm following the successful treatment of advanced Hodgkin’s disease. Cancer 52: 2209–2213PubMedGoogle Scholar
  18. Ben-Yehuda D, Krichevsky S, Caspi O et al. (1996) Microsatellite instability and p53 mutations in therapy-related leukemia suggest mutator phenotype. Blood 88: 4296–4303PubMedGoogle Scholar
  19. Beral V, Inskip H, Fraser P, Booth M, Coleman D, Rose G (1985) Mortality of employees of the United Kingdom Atomic Energy Authority, 1946–1979. Brit Med J 291: 440–447Google Scholar
  20. Bhatia S, Robinson LL, Oberlin O, Greenberg M, Bunin G, Fossati-Bellani F, MD, Meadows A (1996) Breast cancer and other second neoplasms after childhood Hodgkin’s disease. N Engl J Med 334: 745–750PubMedGoogle Scholar
  21. Bithell JF, Stewart AM (1975) Pre-natal irradiation and childhood malignancy. A review of British data from the oxford survey. Br J Cancer 31: 271–287Google Scholar
  22. Bizzozero DJ, Johnson KG, Giocco A (1966) Radiation-related leukemia in Hiroshima and Nagasaki, 1946–1964. New Engl J Med 274: 10951101Google Scholar
  23. Boice JD Jr, Blettner M, Kleinerman RA et al. (1979) Radiation dose and leukaemia risk in patients treated for cancer of the cervix.J Natl Cancer Inst 79: 1295–1310Google Scholar
  24. Boice JD Jr, Land CE, Norman JE,Tokunaga M (1979) Risk of breast cancerGoogle Scholar
  25. following low-dose radiation exposure. Radiology 131:589–597 Boice JD Jr, Mandel JS, Doody MM (1995) Breast cancer among radiologicGoogle Scholar
  26. technologists.J Amer Med Assoc 274:394–401Google Scholar
  27. Boice JD, Day NE, Andersen A et al. (1985) Second cancers following radiation treatment for cervical cancer. An international collaboration among cancer registries.J Natl Cancer Inst 74: 955–975Google Scholar
  28. Boice JD, Engholm G, Kleinerman RA et al. (1988) Radiation dose and second cancer risk in patients treated for cancer of the cervix. Rad Research 116: 3–55Google Scholar
  29. Boice JD, Land CE, Preston DL (1996) Ionizing radiation. In: Schottenfeld D, Fraumeni Jr JF (eds) Cancer epidemiology and prevention, 2nd edn. Oxford University Press, New York, OxfordGoogle Scholar
  30. Boivin J-F, Hutchison GB, Lyden M, Godbold J, Chorosh J, Schottenfeld D (1984) Second primary cancers following treatment of Hodgkin’s disease.J Natl Cancer Inst 72: 233–241Google Scholar
  31. Boivin J-F, O’Brien K (1988) Solid cancer risk after treatment of Hodgkin’s disease. Cancer 61: 2541–2546PubMedGoogle Scholar
  32. Boivin J-F (1990) Second cancers and other late side effects of cancer treatment. Cancer 65: 770–775PubMedGoogle Scholar
  33. Bokemeyer C, Schmoll HJ (1993) Secondary neoplasms following treat- ment of malignant germ cell tumors.J Clin Oncol 11: 1703–1709Google Scholar
  34. Bokemeyer C, Schmoll HJ (1995) Treatment of testicular cancer and the de- velopment of secondary malignancies.J Clin Oncol 13: 283–292Google Scholar
  35. Bookman MA, Longo DL, Young RC (1988) Late complications of curative treatment in Hodgkin’s disease. J Amer Med Assoc 260: 680–688Google Scholar
  36. Breckow J (1991) Zur Bewertung des Krebsrisikos durch ionisierende Strahlung nach der Dosimetrierevision von Hiroshima und Nagasaki. Medizin Klin 86: 92–92Google Scholar
  37. Buglova EE, Kenigsberg JE, Sergeeva NV (1996) Cancer of risk estimation in Belarussian children due to thyroid irradiation as a consequence of the Chernobyl nuclear accident. Health Physics 71: 45–49PubMedGoogle Scholar
  38. Cardis E, Gilbert ES, Carpenter L et al. (1995) Effects of low doses and low dose rates of external ionizing radiation. Cancer mortality among nuclear industry workers in three countries. Rad Research 142: 117132Google Scholar
  39. Cnattingius S, Zack MM, Ekbom A, Gunnarskog J, Kreuger A, Linet M, Adami HO (1995) Prenatal and neonatal risk factors for childhood lymphatic leukemia.J Nat Cancer Inst 87: 908–914Google Scholar
  40. Coltman CA, Dixon DO (1982) Second malignancies complicating Hodgkin’s disease. A Southwest Oncology Group 10-year follow up. CancerTreatm Rep 66: 1023–1033Google Scholar
  41. Cremer C, Cremer T, Popp S, Durm M, Hausmann M (1995) Moderne Chromosomentests zur schnellen Detektion von Aberrationen in der biologischen Dosimetrie. Dtsch Ärztebl 92: 108114Google Scholar
  42. Curtis RE, Boice JD Jr, Stovall M et al. (1992) Risk of leukaemia after chemotherapy and radiation treatment for breast cancer. N Engl J Med 326: 1745–1751PubMedGoogle Scholar
  43. Damber L, Larsson LG, Johansson L, Norin T (1995) A cohort study with regard to the risk of haematological malignancies in patients treated with x-rays for benign lesions in the locomotor system. 1. Epidemiological analyses.Acta Oncol 34: 713–719Google Scholar
  44. Darby SC, Doll R,Gill SK,Smith PG (1987) Long term mortality after a single treatment course with x-rays in patients treated for ankylosing spondylitis. Brit J Cancer 55: 179–190Google Scholar
  45. Darby SC, Reeves G, Key T, Doll R, Stovall M (1994) Mortality in a cohort of women given x-ray therapy for metropathia haemorrhagica.IntJ Cancer56:793–801Google Scholar
  46. Davis FG, Boice JD Jr, Hrubec Z, Monson RR (1989) Cancer mortality in a radiation-exposed cohort of Massachusetts tuberculosis patients. Cancer Res 49: 6130–6135PubMedGoogle Scholar
  47. de Groot U, Reilly M, Pinnameneni K, Refetoff S (1983) Retrospective and prospective study of radiation-induced thyroid disease. Amer J Med 74: 852–862Google Scholar
  48. deVathaire F,Schlumberger M,Delisle MJ et aí. (1997) Leukaemias and cancers following iodine-131 administration for thyroid cancer. Br J Cancer75: 734–739Google Scholar
  49. Devereux S, Selassie TG, Hudson GV, Hudson VB, Linch DC (1990) Leukaemia complicating treatment for Hodgkin’s disease:the experience of the British National Lymphoma Investigation. Brit Med J 301: 1077–1080PubMedGoogle Scholar
  50. Doll R, Evans HJ, Darby SC (1994) Paternal exposure not to blame. Nature 367: 678–680PubMedGoogle Scholar
  51. Donaldson SS, Kaplan HS (1982) Complications of treatment of Hodgkin’s disease in children. Cancer Treatment Rep 66: 977–989Google Scholar
  52. Dorreen MS, Gregory WM, Wrigley PFM, Stansfeld AG, Lister TA (1986) Second primary malignant neoplasms in patients treated for Hodgkin’s disease at St Bartholomew’s Hospital. Hematol Onco14: 149–161Google Scholar
  53. Favus MJ, Schneider AB, Stachura ME et al. (1976) Thyroid cancer occurring as a late consequence of head-and-neck irradiation. N Engl J Med 294: 1019–1025PubMedGoogle Scholar
  54. Fisher B, Rockette H, Fisher ER,Wickerham DL, Redmond C, Brown A (1985) Leukemia in breast cancer patients following adjuvant chemotherapy or postoperative radiation: the NSABP experience. J Clin Oncol 3: 1640–1658PubMedGoogle Scholar
  55. Folley JH, Borges W, Yamawaki T (1952) Incidence of leukemia in survivors of the atomic bomb in Hiroshima and Nagasaki,Japan.AmerJ Med 13: 311–321Google Scholar
  56. Fraumeni JF, Miller RW (1967) Epidemiology of human leukemia: recent observations.J Natl Cancer Inst 38: 593–605Google Scholar
  57. Gardener MJ, Snee MP, Hall AJ, Powell CA, Downes S, D’Terrell J (1990) Results of case-control study of leukaemia and lymphoma among young people near Sellafield nuclear plant in West Cumbria. Brit Med J 300: 423–429Google Scholar
  58. Gassmann W, Slanina J (1993) Langzeittoxizität kurativer Lymphomtherapie. Internist 34: 161–169PubMedGoogle Scholar
  59. Geller RB, Boone LB, Karp JE, Davidson N, Selonick SE, Edwards J, Burke PJ (1984) Secondary acute myeíocytic leukemia after adjuvant therapy for early-stage breast carcinoma. Cancer 64: 629–634Google Scholar
  60. Gilbert ES, Fry SA,Wiggs LD,Voelz GL, Gragle DL, Petersen GR (1989) Analyses an combined mortality data an workers at the Hansford Site, OakGoogle Scholar
  61. Ridge National Laboratory and Rocky Flats Nuclear Weapons Plant. Rad Research 120:19–35Google Scholar
  62. Gilmann EA, Wilson LM, Kneale GW, Waterhouse JAH (1989) Childhood cancers and their association with pregnancy drugs and illnesses. Paed Perinat Epidem 3: 66–94Google Scholar
  63. Glanzmann C,Veraguth A, Lutolf UM (1994) Incidence of second solid cancer in patients after treatment of Hodgkin’s disease. Strahlenther Onkol 170: 140–146Google Scholar
  64. Glicksman AS, Pajak Th-F, Gottlieb A, Nissen N, Sutzman L, Cooper MR (1982) Second malignant neoplasms in patients successfully treated for Hodgkin’s disease. A Cancer and Leukemia Group B study. Cancer Treatment Rep 66: 1035–1044Google Scholar
  65. Greaves MF (1997) Aetiology of acute leukaemia. Lancet 349:344–349 Groves FD, Linet MS, Devesa SS (1995) Patterns of occurrence of the leukaemias.Europ J Cancer 31 A: 941–949Google Scholar
  66. Gutjahr P (1993) Sekundärmalignome nach Krebserkrankungen bei Kindern. Dt Ärztebl 90: 1135–1142Google Scholar
  67. Hancock SL,Tucker MA, Hoppe RT (1993) Breast cancer after treatment of Hodgkin’s disease.J Nat Cancer Inst 85: 25–31Google Scholar
  68. Harvey EB, Boice JD Jr, Honeyman M, Flannery JT (1985) Prenatal X-ray ex-Google Scholar
  69. posure and childhood cancer in twins. N Engl J Med 312:541–545 Hawkins MM., Draper GJ, Kingston JE (1987) Incidence of second primaryGoogle Scholar
  70. tumours among childhood cancer survivors. Br J Cancer 56:339–347 Hempelmann LH (1967) Neoplasms in youthful populations following X-Google Scholar
  71. ray treatment in infancy. Environ Research 1:338–358Google Scholar
  72. Henry-Amar M, Pellae-Cosset B, Bayle-Weisgerber C, Hayat M, Cosset JM, Carde P, Tubiana M (1989) Risk of secondary acute leukemia and preleukemia after Hodgkin’s disease.The Institute Gustave-Roussy Experience. Rec Res Cancer Res 117: 270–283Google Scholar
  73. Herrmann T, Rupprecht E, Voigtmann L, Kuchheuser W (1988) Kinder präkonzeptionell bestrahlter Eltern - eine Longitudinalstudie (Ergebnisse 1986).Strahlenther Onkol 164:629637Google Scholar
  74. Heyn R, Haeberlen V, Newton WA (1993) Second malignant neoplasms in children treated for rhabdomyosarcoma. J Clin Oncol 11: 262–270PubMedGoogle Scholar
  75. Heyssel R, Brill AB, Woodbury LA, Nishimura ET,GhoseT,HoshinoT,Yamasaki M (1960) Leukemia in Hiroshima Aomic bomb survivors. Blood 9: 313–331Google Scholar
  76. Hildreth NG, Shore RE, Dvoretsky PM (1989) The risk of breast cancer after irradiation of the thymus in infancy. N Engl J Med 321: 1281–1284PubMedGoogle Scholar
  77. Hjalmars U, Kulldorff M, Gustafsson G, Kulldorff M, Gustafsson G an behalf of the Swedish Child Leukaemia Group (1994) Risk of acute childhood leukaemia in Sweden after the Chernobyl reactor accident. Brit Med J 309: 154–157Google Scholar
  78. Holowaty EJ, Darlington GA, Gajalakshmi CK,Toogood PB, Levin W (1995) Leukaemia alter irradiation for endometrial cancer in Ontario. Cancer 76: 644–649Google Scholar
  79. Horwich A, Bell J (1994) Mortality and cancer incidence following radiotherapy for seminoma of the testis. Radiother Oncol 30: 193–198PubMedGoogle Scholar
  80. Howe GR (1995) Lung cancer mortality between 1950 and 1987 after exposure to fractionated moderate-dose-rate ionizing radiation in the Canadian fluoroscopy cohort study and a comparison with lung cancer mortality in the atomic bomb survivors study. Rad Research 142: 295–304Google Scholar
  81. Hunger SP, Sklar 1, Link MP (1992) Acute lymphoblastic leukemia occurring as a second malignant neoplasm in childhood: report of three cases and review of the literature.J Clin Oncol 10: 156–163Google Scholar
  82. Ichimaru M,Tomonaga M,AmenomoriT,MatsuoT (1991) Atomic bomb and Ieukemia.J Rad Research 2: 14–19Google Scholar
  83. Inskip PD, Monson RR, Wagoner JK, Stovall M, Davis FG, Kleinerman RA, Boice JD Jr (1990) Leukemia, Lyrnphoma and multiple myeloma after pelvic radiotherapy for benign disease. Rad Research 122: 107–119Google Scholar
  84. Inskip PD, Stovall M, FlanneryJT (1994) Lung cancer risk and radiation dose among women treated for breast cancer.) Nat Cancer Inst 86: 983–988Google Scholar
  85. Ivanov VK,Tsyb AF, Gorsky Al et al. (1997) Leukaemia and thyroid cancer in emergency workers of the Chernobyl accident:estimation of radiation risks (1986–1995). Rad Environ Biophys 36: 9–16Google Scholar
  86. Jablon S, Belsky JL,Tachikawa K,Steer A (1971) Cancer in Japanese exposed as children to Aomic bombs. Lancet 1: 927–932Google Scholar
  87. Joss R, Brunner K, Greiner R (1981) Spätkomplikationen der Behandlung maligner Lymphome.Therapeut Umschau 38: 912–919Google Scholar
  88. Kai M, Luebeck EG, Moolgavkar 5H (1997) Analysis of the incidence of solid cancer among Aomic bomb survivors using a two-stage model of carcinogenesis. Rad Research 148: 348–358Google Scholar
  89. Kaldor JM, Day NE, Clarke EA (1990) Leukemia following Hodgkin’s disease. New Engl J Med 322: 7–13PubMedGoogle Scholar
  90. Kato H (1971) Mortality in children exposed to the a-bombs while in utero. Amer J Epidem 93: 435–442Google Scholar
  91. Kaye SA, Robinson LL, Smithson WA, Gunderson P, King FL, Neglia JP (1991) Maternal reproductive history and birth characteristics in childhood acute lymphoblastic leukemia. Cancer 68: 1351–1355PubMedGoogle Scholar
  92. Kazakov VS, Demidchik EP, Astakhova LN (1992) Thyroid cancer after Chernobyl. Nature 359: 21PubMedGoogle Scholar
  93. Kellerer AM, Nekolla E (1997) Neutron versus gamma-ray risk estimates. Inferences from the cancer incidence and mortality data in Hiroshima. Rad Environ Bioph 36: 73–87Google Scholar
  94. Kendall GM, Muirhead CR, MacGibbon BH et al. (1992) Mortality and occupational exposure to radiation:first analysis of the National Registry for Radiation Workers. Brit Med J 304: 220225Google Scholar
  95. Kinlen U,Clarke K, Balkwill A (1993) Paternal preconceptional radiation exposure in the nuclear industry and leukaemia and non-Hodgkin’s lymphoma in young people in Scotland. Brit Med J 306: 1153 1158Google Scholar
  96. Kinlen U, Dickson M, Stiller CA (1995) Childhood leukaemia and non-Hodgkin’s lymphoma near large rural construction sites, with a cornparison with Sellafield nuclear site. Brit Med J 310: 763–768PubMedGoogle Scholar
  97. Kinsella TJ, Fraass BA, Glatstein E (1982) Late effects of radiation therapy in the treatment of Hodgkin’s. Cancer Treatment Rep 66: 991–1001Google Scholar
  98. Kleinerman RA, Boice JD Jr, Storm HH et al. (1995) Second primary cancer after treatment for cervical cancer. Cancer 76: 442–452PubMedGoogle Scholar
  99. KlugbauerS,LengfelderE,DemidchikEP,RabesHM (1995) High prevalence of RET rearrangement in thyroid tumors of children from Belarus after Chernobyl reactor accident.Oncogene 11: 2459–2461Google Scholar
  100. Koletsky AJ, Bertino JR, Farber LR, Prosnitz LR, Kapp DS, Fischer D, Portlock CS (1986) Second neoplasms in patients with Hodgkin’s disease following combined modality therapy–the Yale experience. J Clin Onco14: 311–317Google Scholar
  101. Kuettel MR,Thraves PJ, Jung M,Varghese SP, Prasad SC, Rhim JS, Dritschilo A (1996) Radiation-induced neoplastic transformation of human prostate epithelial cells. Cancer Res 56: 5–10Google Scholar
  102. Kushner BH,Zauber A,Tan CTC (1988) Second malignancies after childhood Hodgkin’s disease. Cancer 62: 1364–1370Google Scholar
  103. Lane DP (1993) p53- the guardian of the genome. Nature 358:15–16 Lavey RS, Eby NL, Prosnitz LR (1990) Impact of radiation therapy and/orGoogle Scholar
  104. chemotherapy an the risk for a second malignancy after breast can-Google Scholar
  105. cer. Cancer 66:874–881Google Scholar
  106. Lavey RS, Eby NL, Prosnitz LR (1990) Impact an second malignancy risk of the combined use of radiation and chemotherapy for lymphomas. Cancer 66: 80–88PubMedGoogle Scholar
  107. Lindberg S, Karlsson P, Arvidsson B, Holmberg E, Lunberg LM, Wallgren A (1995) Cancer incidence after radiotherapy for skin haemangioma during infancy. Acta Onco134: 735–740Google Scholar
  108. Little MP, Muirhead CR (1996) Evidence for curvilinearity in the cancer incidence dose-response in the Japanese atomic bomb survivors. Int J Rad Bio170: 83–94Google Scholar
  109. Lundell M, Fürst CJ, Hedlund B, Holm LE (1990) Radium treatment for hemangioma in early childhood. Reconstruction and dosimetry of treatments, 1920–1959. Acta Onco129: 551–556Google Scholar
  110. Lundell M, Holm LE (1996) Mortality from leukemia after irradiation in infancy for skin hemangioma. Rad Research 145: 595–601Google Scholar
  111. Lundell M, Holm LE (1995) Risk of solid tumors after irradiation in infancy. Acta Onco134: 727–734Google Scholar
  112. Lundell M, Mattsson A, Hakulinen T, Holm LE (1996) Breast cancer after radiotherapy for skin hemangioma in infancy. Rad Research 145: 225230Google Scholar
  113. MacDougall BK, Weinerman BH, Kernel S (1981) Second malignancies in non-Hodgkin’s lymphoma. Cancer 48: 1299–1301PubMedGoogle Scholar
  114. MacLaughlin JR,Kreiger N,Sloan MP,Benson LN,Hilditch S,Clarke EA (1993) A historical cohort study of cardiac catheterization during childhood and the risk of cancer. lnt J Epidem 22: 584–591Google Scholar
  115. MacMahon B (1962) Prenatal X-ray exposure and childhood cancer.J Natl Cancer Inst 28: 1173–1191Google Scholar
  116. Maillie HD, Gilda JE (1993) Radiation-induced cancer risk in radiographic cephalometry.Oral Surg Med Pathol 75: 631–637Google Scholar
  117. Mattsson A, Hall P, Ruden BI, Rutqvist LE (1997) Incidence of primary malignancies other than breast cancer among women treated with radiation therapy for benign breast disease. Rad Research 148: 152–160Google Scholar
  118. Meadows AT, Hobbie WL (1995)The medical consequences of cure.Cancer 58:524–528Google Scholar
  119. Meadows AT (1988) Risk factors for second malignant neoplasms: reportGoogle Scholar
  120. from the Tate effects study group. Bull Cancer 75:125–130Google Scholar
  121. Meadows AT (1995) Curing cancer in children: minimizing price, maximiz-Google Scholar
  122. ing value.J Clin Oncol 13:1837–1839Google Scholar
  123. Mike V, Meadows AT, D’Angio GJ (1982) Incidence of second malignant neoplams in children. Results of an international study. Lancet 2: 1326–1331Google Scholar
  124. Miller AB, Howe GR, Sherman GJ, Lindsay JP, Yaffe MJ, Dinner PJ, Risch HA, Preston DL (1989) Mortality from breast cancer after irradiation during fluoroscopic examinations in patients being treated for tuberculosis. N Engl J Med 321: 1285–1289PubMedGoogle Scholar
  125. Mole RH (1974) Antenatal irradiation and childhood cancer. Causation or coincidence? BrJ Cancer 30: 200–208Google Scholar
  126. Moloney WC, Lange RD (1954) Leukemia in atomic bomb survivors. Blood 9: 663–685PubMedGoogle Scholar
  127. Neth R (1998) Radioaktivität and Leukämie. Dtsch Ärztebl 27: AGoogle Scholar
  128. 1740-.
    –1406,C1282–1284Google Scholar
  129. Neugut Al, Ahsan H, Antman KH (1997) Incidence of malignant pleural mesothelioma after thoracic radiotherapy. Cancer 80: 948–950PubMedGoogle Scholar
  130. Neugut Al, Robinson E, Lee WC, Murray T, Karwoski K, Kutcher GJ (1993) Lung cancer after radiation therapy for breast cancer. Cancer. 71: 3054–3057PubMedGoogle Scholar
  131. Nussbaum RH, Köhnlein W, Belsey RE (1991) Die neueste Krebsstatistik der Hiroshima-Nagasaki-Überlebenden. Med Klinik 86: 99–108Google Scholar
  132. Olsen JH,Garwicz S, Hertz H et aí. (1993) Second malignant neoplams after cancer in childhood or adolescence. Brit Med J 307: 1030–1036Google Scholar
  133. Pacini F, Vorontsova T, Demidchik EP et al. (1997) Post-Chernobyl thyroid carcinoma in Belarus children and adolescents: comparison with naturally occurring thyroid carcinoma in Italy and France.J Clin Endocrin Metab 82: 3563–3569Google Scholar
  134. Parker L, Craft AW, Smith J, Dickinson H et al. (1993) Geographical distribution of preconceptional radiation doses to fathers employees at the Sellafield nuclear installation, West Cumbria. Br Med J 307: 966–971Google Scholar
  135. Parkin DM, Clayton D, Black RJ et al. (1996) Childhood leukaemia in Europe after Chernobyl. 5 year follow-up. Br J Cancer 73: 1006–1012PubMedGoogle Scholar
  136. Parkin DM, Stiller CA, Draper GJ, Bieber CA (1988) The international incidence of childhood cancer. Int J Cancer 42: 511–520PubMedGoogle Scholar
  137. Petridue E,Trichopoulos D, Dessypris N et al. (1996) Infant leukaemia afterGoogle Scholar
  138. in utero exposure to radiation from Chernobyl. Nature 382:352–353 Pierce DA, Preston DL (1993) Joint analysis of site-specific cancer risks forGoogle Scholar
  139. the atomic bomb survivors. Rad Research 134:134–142Google Scholar
  140. Pierce DA, Shimizu Y, Preston DL,Vaeth M, Mabuchi K (1996) Studies of the mortality of atomic bomb survivors. Report 12, Part 1 Cancer, 1950–1990.Rad Res 146: 1–27Google Scholar
  141. Potish RA, Dehner LP, Haselow RE, Kim TH, Levitt SH, Nesbit M (1985) The incidence of second neoplasms following megavoltage radiation for pediatric tumors. Cancer 56: 1534–1537PubMedGoogle Scholar
  142. Preston D (1995) Cancer risks and biomarker studies in the atomic bomb survivors. Stem Cells 13 [Suppl 1]: 40–48PubMedGoogle Scholar
  143. Preston DL, Kusumi S,Tomonaga M et al. (1994) Cancer incidence in atomic bomb survivors. Part Ill. Leukemia, lymphoma and multiple myeloma, 1950–1987. Rad Res 137: 68–97Google Scholar
  144. Prior P, Pope DJ (1988) Hodgkin’s disease: subsequent primary cancers in relation to treatment. Br J Cancer 58: 512–517PubMedGoogle Scholar
  145. Rabenhorst G, Tsokos M, Freitag F, Wienegge C (1998) Ein Register für Schilddrüsenerkrankungen. Pathologe 19: 1–8Google Scholar
  146. Refetoff S, Harrison J, Karanfilski BT, Kaplan EL, De Groot LJ, Bekerman C (1975) Continuing occurrence of thyroid carcinoma after irradiation to the neck in infancy and childhood. N Engl J Med 292: 171–175PubMedGoogle Scholar
  147. Reinhold DS,Walicka M,ElkassabyM,Milam LD,Kohler5K,Dunstan RW, McCormick JJ (1996) Malignant transformation of human fibroblasts by ionizing radiation. Int J Radiat Biol 69: 707–715Google Scholar
  148. Riches AC, Hergeg Z, Bryant PE, Wynford-Thomas D (1994) Radiation-induced transformation of SV40-immortalized human thyroid epithelial cells by single and fractionated exposure to y-irradiation in vitro. lnt J Radiat Biol 66: 757–765Google Scholar
  149. Rister M,Müller AM,Gladtke E (1983) Kinder ehemalig krebskranker Patienten. Dtsch Med Wschr 108: 1137–1142Google Scholar
  150. Robertson CM, Hawkins MM, Kingston JE (1994) Late deaths and survivalGoogle Scholar
  151. after childhood cancer: implications for cure. Br Med J 309:162–166 Ron E, Modan B, Boice JD (1988) Mortality after radiotherapy for ringwormGoogle Scholar
  152. of the scalp. Amer J Epidem 127:713–725Google Scholar
  153. Sabatier L, Lebeau J, Dutrillaux B (1995) Ionizing radiation and cancer prevention. Environ Health Persp 103: 241–243Google Scholar
  154. Sabatier L, Lebeau J, Dutrillaux B (1995) Radiation induced carcinogenesis: individual sensitivity and genomic instability.Rad Environ Biophys 34: 229–232Google Scholar
  155. Saku T, Hayashi Y, Takahara O et al. (1997) Salivary gland tumors among atomic bomb survivors,1950–1987.Cancer 79: 1465–1475Google Scholar
  156. Sali D, Cardis E, Sztanyik L et al. (1996) Cancer a consequence of the Chernobyl accident in Europe outside the former USSR: a review. Int J Cancer67: 343–352Google Scholar
  157. Scaradavou A, Heller G,Sklar CA, Ren L, Ghavimi F (1995) Second Malignant neoplasms in long term survivors of childhood rhabdomyosarcoma. Cancer 76: 1860–1867Google Scholar
  158. Schellong G, Riepenhausen M, Creutzig U, Ritter J, Harbott J, Mann G, Ladner H (1997) Low risk of secondary leukemias after chemotherapy without mechloretamine in childhood Hodgkin’s disease.J Clin Oncol 15: 2247–2253Google Scholar
  159. Schwenn MR, Brill AB (1997) Childhood cancer 10 years after the Chernobyl accident (review). Current Opinion Paed 9: 51–54Google Scholar
  160. Shimizu Y, Kato H,Schull WJ (1990) Studies of the mortality of A bomb survivors. Mortality, 1950–1985. Part 2: Cancer mortality based an the revised doses (D586). Rad Res 121: 120–141Google Scholar
  161. Shore RE (1990) Overview of radiation induced skin cancer in humans. Int J Radiat Bio157: 809827Google Scholar
  162. Shore RE, Alber RE, Pasternack PS (1976) Follow-up study of patients treated by X-ray epilation for tines capitis. Arch Environ Health 31: 21–28PubMedGoogle Scholar
  163. Shore RE, Hildreth N, Dvoretsky P, Pasternack B, Andresen E et al. (1993) Benign thyroid adenomas among persons X-irradiated in infancy for enlarged thyrnus glands. Rad Res 134: 217–223Google Scholar
  164. Smith G, Doll R (1982) Mortality among patients with ankylosing spondylitis after a single treatment course with x-rays. Brit Med J 284: 449460Google Scholar
  165. Spengler RF, Cook DH, Clarke EA, 011ey PM, Newman AM (1983) Cancer mortality following cardiac catheterization. A preliminary follow-up study an 4,891 irradiated children. Pediatrics 71: 235–239PubMedGoogle Scholar
  166. Spiess H, Mays CW (1970) Bone cancers induced by 224Ra ( Th X) in children and adults. Health Physics Pergamon Press 19: 713–729Google Scholar
  167. Stewart A,Webb J, Hewitt D (1958) A survey of childhood malignancies. Brit Med J 1: 1495–1508Google Scholar
  168. Straume T, Bender MA (1997) Issues in cytogenetic biological dosimetry:Google Scholar
  169. emphasis on radiation environments in space. Rad Res 148:60–70 Swerdlow AJ, Douglas AJ,Vaughan Hudson G,Vaughan Hudson B, BennettGoogle Scholar
  170. MH, MacLennan KA (1992) Risk of second primary cancers afterGoogle Scholar
  171. Hodgkin’s disease by type of treatment:analysis of 2846 patients in the British National Lymphoma Investigation. Brit Med J 304:1137–1143Google Scholar
  172. TesterW,KinsellaT,WallerB,Makuch R,Glatstein E (1983) Second malignant neoplasms (SMN) Complicating Hodgkin’s disease (HD). Proc Am Soc Clin Oncol 3: 222Google Scholar
  173. Thar TL, Million RR (1980) Complications of radiation treatment of Hodgkin’s disease. Sem Oncol 7: 174–183Google Scholar
  174. Thompson DE, Mabuchi K, Ron E et al. (1994) Cancer incidence in atomic bomb survivors. Part 11: solid tumors,1958–1987. Rad Res 137: 17–67Google Scholar
  175. Thraves P, Salehi Z, Dritschilo A, Rhim JS (1990) Neoplastic transformation of immortalized human epidermal keratinocytes by ionizing radiation. Proc Natl Acad Sci USA 87: 1174–1177PubMedGoogle Scholar
  176. Travis LB, Curtis RE, Gilmelius B et al. (1993) Second cancers among longterm survivors of Non-Hodgkin’s lymphoma. J Natl Cancer Inst 85: 1932–1937PubMedGoogle Scholar
  177. Travis LB, Curtis RE, MS, Boice LD Jr, Hankey BF, Fraumeni JF Jr (1991) Second cancers following Non-Hodgkin’s lymphoma. Cancer 67: 2002–2009PubMedGoogle Scholar
  178. Tucker MA, Coleman CN, Cox RS,Varghese A, Rosenberg SA (1988) Risk of second cancers after treatment for Hodgkin’s disease. N Engl J Med 318: 76–81Google Scholar
  179. Valagussa P, Santoro A, Fossati-Bellani F, Banf A, Bonadonna G (1986) Second acute leukemia and other malignancies following treatment for Hodgkin’s disease.J Clin Onco14:830–837Google Scholar
  180. Valagussa P, Tancini G, Bondadonna G (1987) Second malignancies after CMF for resectable breast cancer.J Clin Oncol 5: 1138–1142Google Scholar
  181. Van Kaick G,Wesch H, Luhrs H, Liebermann D, Kaul A (1991) Neoplastic diseases induced by chronic alpha-irradiation–epidemiological, biophysical and clinical results of the German thorotrast study.J Rad Research 32 [Suppl 2]: 20–33Google Scholar
  182. Van Leeuwen FE,Somers R, Hart AAM (1987) Splenectomy in Hodgkin’s disease and second leukaemias. Lancet 2: 210–211Google Scholar
  183. Van Leeuwen, FE, Stiggelbout AM, van den Belt-Dusebout AW et al. (1993) Second cancer risk following testicular cancer: a follow-up study of 1,909 patients.J Clin Oncol 11: 415–424Google Scholar
  184. Van Leeuwen FE,Klokman WJ,HagenbeekAet al. (1994) Second cancer risk following Hodgkin’s disease.A 20-year follow-up study.J Clin Oncol 12: 312–325Google Scholar
  185. Vlachaki MT, Ha CS, Hagemeister FB et al. (1997) Long-term outcome of treatment for Ann Arbor stage 1 Hodgkin’s disease: Patterns of failure, late toxicity and second malignancies. Int J Rad Oncol Biol Phys 39: 609–616Google Scholar
  186. Wakeford R, Parker L (1996) Leukaemia and non-Hodgkin’s lymphoma in young persons resident in small areas of West Cumbria in relation to paternal preconceptional irradiation. Br J Cancer 73: 672–279PubMedGoogle Scholar
  187. Wakeford R, Tawn EJ (1995) Re: Effects of preconceptional irradiation an mortality and cancer incidence in the offspring of patients given injektions of thorotrast.J Nat Cancer Inst 87: 606–607Google Scholar
  188. Wazer DE, Chu Q, Liu XL, Gao Q, Safah H, Band V (1994) Loss of p53 protein during radiation transformation of primary human mainmary epithelial cells. Mol Cell Biol 14: 2468–2478PubMedGoogle Scholar
  189. Weiss HA, Darby SC, Feam T, Doll R (1995) Leukemia mortality after X-ray treatment for ankylosing spondylitis. Rad Res 142: 1–11Google Scholar
  190. Wolden SL, Lamborn KR, Cleary SF, Tate DJ, Donaldson SS (1998) Second cancer following pediatric Hodgkin’s disease.J Clin Oncol 16: 536–544Google Scholar
  191. Xin L, Lane DP (1993) Differential induction of transcriptionally active p53 following UV or ionizing radiation: Defects in chromosome instability syndromes? Cell 75: 765–778Google Scholar
  192. Yamada M, Kodama K, Fujita S, Akahoshi M, Yamada S, Hirose R, Hori M (1996) Prevalence of skin neoplasms among the atomic bomb survivors. Rad Res 146: 223–226Google Scholar
  193. YoshimotoY (1990) Cancer risk among children of atomic bomb survivors. J Am Med Assoc 264: 596–600Google Scholar
  194. Yoshimoto Y, Kato H, Schull WJ (1988) Risk of cancer among children ex- posed in utero to abomb radiations, 1950–84. Lancet 2: 665–669PubMedGoogle Scholar
  195. Yoshimoto Y, Neel JV,Schull WJ, Kato H,Soda M, Eto R, Mabuchi K (1990) Malignant tumors during the first 2 decades of life in the offspring of atomic bomb survivors. Am J Hum Genet 46: 1041–1052Google Scholar
  196. Zadeh HG, Briggs TW (1997) Ionising radiation:are orthopaedic surgeons’ offspring at risk? Ann Royal College Surg Eng179: 214–220Google Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2004

Authors and Affiliations

  • W. Gassmann
  • H. P. Rodemann

There are no affiliations available

Personalised recommendations